• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:

    公开号:SU878197A3
    申请号:SU792791951
    申请日:1979-07-31
    公开日:1981-10-30
    发明作者:Зайдельманн Дитер；Шмихен Ральф；Пашельке Герт；Мюллер Бернд
    申请人:Шеринг Аг (Фирма)；
    IPC主号:
    专利说明:

    ; 54) METHOD OF OBTAINING DERIVATIVES
    FENNLPYRROLIDONE OR THEIR ACID-ADDITIVE SALTS The invention relates to a method for producing new derivatives of phenylpyrrolidone of the general formula I | pYo4sng) „- sysn- (sIG), - Q I t -“ 8 R3 n. where R. is a hydrogen atom or methocoyl, Rg is a hydroxyl group with 1-6 carbon atoms, Rfl, is a hydrogen atom or R and Rg independently of each other means a hydrogen atom, methyl or hydroxyl; hn and or 1, A is an oxygen atom, the OH- or) N-R group,.,. where Rg is a hydrogen atom, groups. (G), l / h V P 7 -J where X is a hydrogen or halogen atom, etoxy or nitro group, or their acid addition salts. Compounds of general formula 1 possess vasodilatory and blood-lowering effects and may be used in medicine. A known method for the production of piperazine derivatives of the formula IV -c — CHa, -N NC-CH or its salts, which consists in that the N- (3,4,5-trimethoxydine) piperazine of the formula Y / HjCO-CH-c is reacted with N-chloroacetylpyrrolidone-2 of formula VI O -SO G1-GH2 in ethyl acetate medium while boiling the reaction mass in the presence of sodium carbonate followed by BE Separating products in free form or as salt E. Purpose of the invention is to obtain new compounds that expand the assortment substances that can be used in medicine as phi ziologicheski active substances. This goal is achieved by the present method of obtaining compounds of the general formula, which consists in the fact that a substituted phenium -2-pyrrolidone of the general formula II HI if () ttrCH-CH- (CH2) "- X" 2 chlorine atom or epoxy group with the carbon atom B of the R-position, the type has the above values, is subjected to; reacting with a secondary cyclic amine of the general formula UNA, where A is as defined above, in an inert solvent with a tag / sherate above room temperature and the final product is isolated in free form or as an acid addition salt. For therapeutic purposes, they are administered from the dinene of formula 1, orally at a daily dose of 0.1-500 mg, preferably 1-50 mg. Orally administered drugs contain a biologically active substance in an amount of 0.05-500 mg, preferably about 0.1-25 mg per dosage unit. For drug administration, biologically active substances can be in the form of tablets, granules, powders, capsules, and the like. The biologically active substance is taken together with auxiliary substances or carriers, such as lactose, stearate magnesium, kaolin, sucrose, corn starch, talc, s.thearic acid, gelatin, agaragar, pectin, etc., example 1. 15 , 5 mmol (2,3-epoxypropoxy) -4-methoxyphenyl-2-pyrrolidone is dissolved in 50 ml of methanol. After addition of 15/5 mmol of 1-phenylpiperazine (95% strength), heat for 3 hours with reflux. After cooling the reaction solution, the solvent is removed under vacuum at 40 ° C. The residue is taken up in 50 ml of 1N hydrochloric acid and extracted twice with 100 ml of chloroform. The aqueous form is alkalinized 2n. with a solution of sodium hydroxide and then extracted three times with ethyl acetate. The combined extracts are washed with a saturated sodium chloride solution, and after drying over sodium sulfate under a subsection, the solvent is distilled off. The residue is recrystallized from ethanol. 61% 4 4-methoxy-3- (4-phenylpiperazin-1-yl) -2-oxypropoxy) phenyl -2-pyrrolidone is obtained with a yield of mp 143-144 ° C. The solution is planted in ether dihydrochloride. M.p. 1b7-169 ° C. (2,3-Epoxypropoxy) -4-methoxyphenyl -2-pyrrolidone (mp. 124-126), used as a starting product, is obtained by reacting 4 (3-hydroxy-4-methosiphenyl) 2-pyrrolidone with epichlorohydrin and hydride sodium in dimethylformamide. Example 2. According to the method described in Example 1, from the 4-C3- (2,3-epoxypropoxy) -4-m-stoxiphenyJ: -2-pyrrolidone and the secondary amine, the compounds listed in the table are obtained, and K-C H2-CH- Sig-O OH Example 3. From 11.5 mmol (2,3-epoxypropoxy) -3-methoxyphenyl 3-2-pyrrolidone and 11.5 mmol 1-phenyl piperazine (95%) are prepared analogously to the method of Example 1 with 74% yield 4-3-methoxy-4-3- (4-phenylpiperazinyl) -2-hydroxypropoxy-phenyl-2-pyrrolidone with a melting point of 123-125 ° C (ethanol; after chromatography in methanol j chloroform 1/1). Used as the starting compound (2,3-epoxypropoxy) -3-methoxyphenyl J-2-pyrrolidone (mp. 108-110 ° C) is obtained by reacting 4- (4-hydroxy-3-methoxyphenyl) -2-pyrpole Schonone with epochlorohydrin and sodium hydride in dimethylformamide. Example 4. From 8, b mol of (2, 3-epoxypropoxy) -phenyl | -2-pyrrolidone and 8.6 ppm of 1-phenylpiperazine (95%) in example 1 is obtained with a 77% yield of 4- 3- 2-hydroxy-3- (4-phenyl-piperazinyl) -propoxy-phenyl-2-pyrrolide With so pl. 8284 ° C (ether, after chromatography in methanol / chloroform 2/8). The (2,3-epoxypropoxy) 3-2-pyrrolidone (oil) used as the starting material is obtained by reacting 4- (3-hydroxyphenyl) -2-pyrrolidone with e-pi, chlorohydrin and sodium hydride in dimethylformamide. Example 5. From 10 mmol of 5-f3- (2,3-epoxypropoxy) -4-methoxyphenyl 3-2-pyrrolidone and 10 ml of 1-phenyl piperazine (95%), is obtained in a 52% yield of 5–3–2- hydroxy-3- (4-phenylpiperazin-1-yl) propoxy 3-4-methoxyphenyl -2-pyrrolidone with mp 127-131 ° C (ethanol).
    Used as the starting compound, (2,3-epoxypropoxy) -4-methoxyphenyl -2-pyrrolidone (mp. 140-142 ° C) is obtained by reacting 5- (3-hydroxy-4-methoxyphenyl) -2-pyrrolidone with epichlorohydrin . sodium hydride in dimethylformamide.
    Example 6. From 10 (2,3-epoxypropoxy) -4-methoxyphenyl1-2 pyrrolidone and 10 mmol of 1-phenylpiperazine (95%), 60% of 3-3 2-hydroxy-3- (4phenylpiperazine-1 -yl) -propoxy J-4-methoxyphenyl -2-pyrrolidone with mp 1446147s. Used as starting material (2,3 epoxy). 4-methoxyphenyl -2-pyrolidonic {m.p. 110-112 c) is obtained by the interaction of 3H-3-hydroxy-4-methoxyphenyl) -2-pyrrolidone with epichlorohydrin with sodium hydride in dimethylformamide.
    Example 7. 20 mmol. (2-Chlorepoxy) -4-methoxyphenyl -2-pyrrolidone is dissolved in 50 ml of dimethylformamide. After the addition of 22 mmol. 1-phenylpiperazine (95%) and 20 mmol of triethylamine are heated
    within 6 hours to 100 ° C. After completion of the conversion, the solvent is distilled off at 40 ° C under high vacuum. The residue is taken up in 50 ml of ethyl acetate, washed with half-saturated sodium chloride solution and, after drying over sodium sulfate, the solvent is distilled off under vacuum.
    With a yield of 15.2%, 4- | 4-methoxy-3-1 2- (4-phenylpiperazin-1-yl) -ethoxy-phenyl) 2-pyrrolidone, m.p. 140-141 C. Salt acid s ether Planted dihydrochloride with so pl.219-221 ° C.
    Used as the starting material, 4-z- (2-chloroethoxy) -4-methoxyphenyl -2-pyrrolidone (mp. 134138 ° C) is obtained by the interaction of 1-, -bromo-2-chloroethane with 4-СЗ-oxy- 4-methoxyphenyl) -2-pyrrolidone and sodium hydride in dmethylformamide.
    Example 8. From 5 mmol of (3-chloropropoxy) -4-methoxyphenyl-2-pyrrolidone and 5.5 mmol of 1-phenylpiperazine (, 95%) were prepared according to Example 7 in a yield of 22.5% of 4-J4-methoxy- 3- (3- (4-phenylpiperazin-1-yl) -propoxy-phenyl -2-pyrrolidone with mp 135-1370C (ethanol). Isol: 3 (3-chloropropoxy) -4-methoxyphenyl as the starting product -2-Pyrrolidone (mp. 123-130 ° C) is obtained by reacting 4- (3-hydroxy-4-methoxyphenyl) -2-pyrrolidone with 1-bromo-3-chloropropane and hydride
    sodium in dimethylformamide.
    Example 9. From 10 mmol of 4- (3-chloropropoxy) -4-methoxyphenyl -2-pyrrolidone and 11 mmol of 4- (4-fluorobenzoyl) -pyreridine are prepared according to example 7 with a 23% yield of 4-4-methoxy-3 - h- (4-fluorobenzoyl) -pyreridin-1-yl3-phenyl} 2-pyrrolidone with so pl. 104-105s (ethanol, after chromatography methanol / chloroform 9/1).
    Example 10. From 20 mmol of 4- (4-bromobutoxy) -4-methoxy, Iphenyl -2-pyrrolidone and 22 mmol of 1-phenyl-piperazine (95%) are obtained in a yield of 30% 4- | 4-methoxy-3-4 - (4 Phenylpiperazin-1-yl) -butoxy3-phenyl} -2-pyrrolidone with mp. 1.23-124 ° C (ethyl acetate). Used as
    0 of the starting material (4-bromobutoxy) -4-methoxyphenylZ-2-pyrrolidone (mp. 116-119 ° C) is obtained mutually. by the action of 4- (3-hydroxy-4-methoxyphenyl) -2-pyrrolidok with 1,4-dibromobutane
    5 and sodium hydride and dimethylformamide.
    Example 11. 7.5 mmol 4- 4-methoxy-3-f 3- (4-piperazin-1-yl) -2-oxypropoxy3-phenyl} -2-pyrrolidone. dissolved in 50 ml of dry pyridine. After adding 15 mg of acetic acid
    0 anhydride is heated for 3 hours with reflux. After cooling, the reaction mixture is concentrated under vacuum. The residue is chromatographed on silica gel (1/3 acetone / dichloromethane) and re-crystallized from isopropanol. 4-i4-Metoxy-3- 3- (4-piperazyl-1-yl) -2-acetopropoxy 3-phenyl -2-pyrrolidone is obtained in 85% yield with m.p. 128-133 ° C.
    D
    Example 12. According to the method described in example 1, from 10 mmol, (1-methyl-2, 3-epoxypropoxy) - -4-methoxyphenyl -2-pyrrolidone and 10 mmol of 1-phenylpiperazine (95%)
    5 in 68% yield, 4- | 4-methoxy-3- {3- (4-phenylpiperazin-1-yl) 1-methyl-2-hydroxyprop; 1 oxy2-phenyl 5 -2-pyrrolidone, m.p. 11b-118s (ethinol).
    Used as source
    0 product (1-methyl-2,3-epoxy) -4-methoxyphenyl -2-pyrrolidone (mp. 1 21-125 ° C) is obtained by the interaction 4- (3-hydroxy-4-methoxyphenyl) -2 -pyrrolidone with 3-bromo-1,2-epoxybutane and sodium hydride in dimethylformamide.
    Example 13. From 10 mmol of (3-bromobutoxy) -4-methoxyphenyl -2-pyrrolidone and 10 mmol of 1-phenylpiperazine (95%) are prepared analogously to Example 7 with a 19.8% yield of 4-4-methoxy 3-Hz- (z-methyl-3- (4-methylpiperazin-1-yl) -propoxyT-phenyl -2-pyrrolidone with mp. 8890 ° C (ethanol, after chromatography
    5 from methanol / chloroform 1/9) -,
    Hydrochloric acid in the air precipitates dig1-schrochloride with m.p. 120 ° C (with decomposition).
    As a starting product, (3-bromo-butoxy) -40-methoxyphenyl} -2-pyrrolidone (oil) is obtained by reacting 1,3-dibromobutane with 4- (3-hydroxy-4-methoxyphenyl) -2-pyrrolidone and sodium hydride in
    5 dimethylformamide.
    -ABOUT
    63 124-126
    MF
    O54, 5 Oil
    Hjco
    oh oh
    61 104-106
    Ethyl acetate 65
    Methanol
    2.5 Methanol
    Chromatography 65 MeOH / hlf, 2/8
    Ethyl acetate65
    Methanol
    DMF - dimethylformamide. where Rj, is a hydrogen atom or methoxy R is an acyloxy group with 1-6 carbon atoms; R is a hydrogen atom or 2 b independently means a hydrogen atom, methyl or hydroxyl; m and or 1, A is an oxygen atom, the group is CH, or s; mk5- ,. where Rf is a hydrogen atom, group-C g- 9 II // X P Y-, - / -sn where X is a hydrogen or halogen atom, methoxy or a nitro group, or their acid additive salts, O where a chlorine atom or an epoxy group with the carbon atom in the p-position,, Rg., R3 have the above values of j and are reacted with a secondary cyclic amine of the general formula III / -HN A gd A And has the above values, in an inert solvent at a temperature above room temperature and the final product is isolated in in free form or in the form of an acid addition salt. Sources of information taken into account in the examination of 1, USSR Patent No. 569289, cl. S 07 O 403/06, published 1977,
    权利要求:
    Claims (1)
    [1]
    Claim
    1. A method for the preparation of phenylpyrrolidone derivatives of the general formula I, characterized in that the substituted phenyl-2-pyrrolidone is general) of the formula if a hydrogen atom or methoxy an acyloxy group with 1-6 carbon atoms;
    a hydrogen atom or R £ H R g independently of one another means a hydrogen atom, methyl or hydroxyl;
    where m and n = 0 or 1,
    A is an oxygen atom, a group, or J N-R5
    R ^ is a hydrogen atom, a group where jd is a chlorine atom or an epoxy group with a carbon atom in the β-position, R /> r 2.> r 3> m and n have the above values; j are reacted with a secondary cyclic amine of the general formula JII ngH ~ d / CH-Rg gd * e A has the above meanings, where X is a hydrogen or halogen atom, methoxy or nitro group, or their acid addition salts, in an inert solvent at a temperature above room temperature and the final product is isolated in free form 25 or in the form acid addition salt
    类似技术:
    公开号 | 公开日 | 专利标题
    FI69839B|1985-12-31|FREQUENCY REQUIREMENT FOR THERAPEUTIC ACTIVATION OF ACTIVE DIPHENYLMETOXYKYLPIPERAZINDERIVAT
    KR890000020B1|1989-03-06|Process for preparing arylthio-hydroxypropyl piperazinyl acetanilides
    SU878197A3|1981-10-30|Method of preparing phenylpyrrolidone derivatives or their acid-additive salts
    GB2225321A|1990-05-30|Process for preparation of a 1-piperazine-ethoxyacetic acid
    US4659818A|1987-04-21|Intermediates for benzylpyrimidines
    SU645553A3|1979-01-30|Method of obtaining benzilamine derivatives or salts thereof
    HU209723B|1994-10-28|Process for producing of piperazine derivatives
    US4377576A|1983-03-22|5-|-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-ones
    US3856794A|1974-12-24|1-phenoxy-3-arylpiperazinyl-2-propanol hypotensives
    US4515944A|1985-05-07|1,5-Diphenyl-2-haloalkylpyrazolin-3-one intermediates
    US3751416A|1973-08-07|3-|-ethyl)indolines
    US4320061A|1982-03-16|2,3,4,5-Tetrahydro-1-benzoxepin-3,5-dione derivatives
    US3988456A|1976-10-26|1,2-Diphenylethanolamine derivatives and their salts and the preparation thereof
    US4517365A|1985-05-14|Isocarbostyril derivative
    SE450120B|1987-06-09|NEW DIMETOXICINAZOLINE DERIVATIVES TO USE FOR PREPARATION OF 2 | -4-AMINO-6,7-DIMETOXICINAZOLINES
    US4374846A|1983-02-22|N-Amino alkyl indole compounds compositions containing same, and a method of using same in therapy of disorders of gastrointestinal motility
    DK151254B|1987-11-16|METHOD OF ANALOGUE FOR THE PREPARATION OF 2-HYDROXYMETHYL-PYRAZINE DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE SALTS THEREOF
    CA2011143C|1999-02-23|Pyridinecarboxylic acid amide derivatives and pharmaceutical compositions comprising same
    GB2043060A|1980-10-01|4-substituted 2-iminoimidazolidine compounds
    CA1123852A|1982-05-18|Cyclododecane derivatives and a process for thepreparation thereof
    EP0033660A1|1981-08-12|2-|-cycloheptimidazole derivatives, processes for their preparation, pharmaceutical compositions containing them, and the preparation of such compositions
    KR20000038041A|2000-07-05|Preparation of 1-butyl-4-piperidinylmethylamine
    US4078141A|1978-03-07|5-|-2-furancarboximidoyl morpholine or pyrrolidine hydrochloride
    US4061776A|1977-12-06|Pharmaceutically active 2-omega-aminoalkoxydiphenyl ethers
    GB2110671A|1983-06-22|1-furyl-3, 4-dihydroisoquinolines
    同族专利:
    公开号 | 公开日
    DK152426B|1988-02-29|
    DD145104A5|1980-11-19|
    IE48915B1|1985-06-12|
    EP0008645B1|1984-09-05|
    ES482917A1|1980-04-16|
    EP0008645A1|1980-03-19|
    DD145104B3|1990-07-18|
    DE2967204D1|1984-10-11|
    CS225816B2|1984-02-13|
    AU533442B2|1983-11-24|
    AU4944079A|1980-02-07|
    DK323179A|1980-02-02|
    IL57926A|1983-10-31|
    IE791453L|1980-02-01|
    IL57926D0|1979-11-30|
    CA1115701A|1982-01-05|
    AT9221T|1984-09-15|
    US4219551A|1980-08-26|
    DE2834114A1|1980-02-14|
    JPH0371423B2|1991-11-13|
    HU183103B|1984-04-28|
    DK152426C|1988-08-29|
    JPS5522686A|1980-02-18|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US3577415A|1968-12-23|1971-05-04|Robins Co Inc A H|1-substituted-3-substituted phenoxypyrrolidines|
    DE2263211A1|1972-12-23|1974-07-04|Boehringer Sohn Ingelheim|NEW ARYLPIPERAZINE AND PROCESS FOR THEIR PRODUCTION|
    DE2337461A1|1973-07-24|1975-02-06|Boehringer Mannheim Gmbh|NEW INDOLDER DERIVATIVES AND PROCESS FOR THEIR PRODUCTION|
    US4120969A|1975-09-23|1978-10-17|A. H. Robins Company, Incorporated|Heterocyclic analgetic and antidiarrheal compounds|
    US4096331A|1976-12-28|1978-06-20|A. H. Robins Company, Incorporated|1-Substituted-3-aminoethoxypyrrolidines|
    DE2737630C2|1977-08-20|1987-11-05|Boehringer Mannheim Gmbh, 6800 Mannheim, De|DE3424685A1|1984-07-05|1986-02-06|Beiersdorf Ag, 2000 Hamburg|NEW SUBSTITUTED PHENYLPIPERAZINYL PROPANOLS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE, AND PREPARATIONS CONTAINING THESE COMPOUNDS|
    SE8500573D0|1985-02-08|1985-02-08|Ferrosan Ab|NOVEL PIPERAZINECARBOXAMIDES HAVING A PHENOXYALKYL OR THIOPHENOXYALKYL SIDE CHAIN|
    EP0288575A4|1986-10-27|1990-10-10|Yoshitomi Pharmaceutical Industries, Ltd.|Piperazine compounds and their medicinal use|
    DE3809031A1|1988-03-15|1989-09-28|Schering Ag|NEW AGENT AGAINST OBSTRUCTIVE BLADDER EMPTYING|
    DE3921593A1|1989-06-28|1991-01-10|Schering Ag|METHOD FOR THE RACEMATE SEPARATION OF 4-ARYL-2-OXO-PYRROLIDIN-3-CARBONIC ACID ESTER|
    DE19648011A1|1996-11-20|1998-05-28|Bayer Ag|Cyclic imines|
    US6930111B2|2001-07-19|2005-08-16|Cv Therapeutics, Inc.|Substituted heterocyclic compounds|
    AU2002335015B8|2001-10-16|2006-11-30|Memory Pharmaceuticals Corporation|4--2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes|
    EP1613590A2|2003-04-16|2006-01-11|Memory Pharmaceutical Corporation|4--pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors|
    RU2379292C2|2003-04-18|2010-01-20|Мемори Фармасьютиклз Корпорейшн|Pyrazole derivatives as phosphodiesterase 4 inhibitors|
    AU2005295753A1|2004-10-15|2006-04-27|Memory Pharmaceuticals Corporation|Pyrazole derivatives as phosphodiesterase 4 inhibitors|
    AU2005295350A1|2004-10-20|2006-04-27|Memory Pharmaceuticals Corporation|Phosphodiesterase 4 inhibitors|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    DE19782834114|DE2834114A1|1978-08-01|1978-08-01|POLYALKOXYPHENYLPYRROLIDONE III, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE|
    [返回顶部]